Summary
Classify the timing and triggers before choosing tests. Dizziness may arise from vestibular, neurological, cardiovascular or other systemic disease. SAEM GRACE-3
Exclude an acute central cause first. New focal signs, severe gait and/or truncal instability, new deafness or a concerning acute headache require urgent assessment; an apparently peripheral feature may be red herring. NICE NG127
1. History and syndrome selection
Time course: onset, first event vs episodic, duration of each attack, frequency, progression and function between attacks. Separate a brief trigger-dependent spell from continuous vertigo that merely worsens when the head moves.
Triggers: rolling in bed/looking up, standing, exertion, visual motion, loud sound and pressure/straining. Clarify whether the trigger starts symptoms or aggravates symptoms already present.
Associated features: hearing change, tinnitus/fullness, headache, migraine sensitivity/aura, diplopia, dysarthria, dysphagia, altered sensation, limb weakness, palpitations and loss of consciousness. Ask directly; neurological or auditory symptoms may not be volunteered.
Context: vascular risks, migraine, neuropathy, visual impairment, trauma/ear surgery, ototoxic drugs, sedatives/alcohol and cardiovascular medicines. Document falls, injury, mobility, work, driving and avoidance.
Presentation | Main assessment question |
|---|---|
Acute vestibular syndrome (AVS): ongoing acute vertigo/dizziness with nausea, head-motion intolerance and imbalance | Peripheral vestibulopathy versus stroke; use the appropriate acute pathway. NICE NG127 SAEM GRACE-3 |
Spontaneous episodic: attacks without a mandatory positional trigger | Migraine/Ménière pattern versus TIA, arrhythmia or another episodic cause; assess associated features. SAEM GRACE-3 |
Triggered episodic: brief spells linked to a specific position or standing | Positional BPPV testing versus postural BP assessment; retain a central differential when atypical. NICE NG127 NICE NG136 |
Persistent imbalance/oscillopsia | Uncompensated or bilateral vestibular loss, neurological/sensory disease, medication and functional contributors. |